1. Laboratory biomarkers associated with mortality in COVID-19 patients in Addis Ababa, Ethiopia
- Author
-
Abay Sisay, Zerihun Woldesenbet, Anteneh Yalew, Aklilu Toma Shamenna, Asnake Worku, Abraham Tesfaye, Fentabil Getnet, Latera Tesfaye, Mohammed B. Hassen, Mulugeta Geleso, Veranyuy D Ngah, Perseverence Savieri, Alemnesh H. Mirkuze, Lovemore Sigwadhi, Adey Feleke Desta, and Peter S Nyasulu
- Abstract
BackgroundLaboratory biomarkers are amongst the best imperative predictors of disease outcomes in hospital-admitted COVID-19 patients. Although data is available in this regard at a global level, there is a paucity of information in Ethiopia. Thus, this study aimed to assess the laboratory biomarkers association with death among COVID-19 patients in Ethiopia.MethodsA health facility-based longitudinal study was conducted from 2020 to 2022 among RT-PCR-confirmed COVID-19 patients admitted and on treatment follow-up at COVID-19 treatment hospitals in Addis Ababa. A robust Poisson regression model was fitted to assess the association between demographic, clinical, and laboratory factors and death. Significance was determined at pResultsOf the 2357 COVID-19 patients, 248 (10.5%) died. The median age of participants was 59 (IQR= 45-70) years, and the majority (64.9%) of them were male. Lower median RBC was observed among those who died at 4.58 (4.06-5.07) as compared to those who survived at 4.69 (4.23-5.12) whereas high median (IQR) WBC was a predictor of mortality with 11.2 (7.7-15.9). After adjusting for confounders, death was associated with age >74 years having adjusted incidence rate ratio [aIRR (95%CI): 2.46 (1.40-4.34)], and critical clinical situations [aIRR (95% CI): 4.04 (2.18-7.52)].ConclusionOur results demonstrate that abnormal liver function tests, abnormal white blood cells, age of the patients, and clinical status of the patients during admission are associated with unfavorable outcomes of COVID-19. Hence, timely monitoring of these laboratory results at the earliest phase of the disease was highly commendable.
- Published
- 2023